CONCORDBIO:NSE
Concord Biotech Ltd
₹ १,३४१.५०
arrow_downward
-०.८७%(-११.८०) 1D
अक्टोबर १६, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CONCORDBIO...
Open
₹ १,३६२.९०
High
₹ १,३६६.८०
Low
₹ १,३३२.००
Mkt. cap
१.४० खरब
Avg. vol.
१.३२ लाख
Volume
४५.३८ हजार
Dividend
०.५६%
Quarterly dividend
₹ १.८९
Ex-dividend date
२०२६ जुलाई २४
P/E ratio
५०.९९
52-wk high
₹ १,६१५.००
52-wk low
₹ ९८७.००
EPS
₹ २६.३१
No. of employees
२ हजार
Open
₹ १,३६२.९०
High
₹ १,३६६.८०
Low
₹ १,३३२.००
Mkt. cap
१.४० खरब
Avg. vol.
१.३२ लाख
Volume
४५.३८ हजार
Dividend
०.५६%
Quarterly dividend
₹ १.८९
Ex-dividend date
२०२६ जुलाई २४
P/E ratio
५०.९९
52-wk high
₹ १,६१५.००
52-wk low
₹ ९८७.००
EPS
₹ २६.३१
No. of employees
२ हजार
News stories
From web sources and news partners
01net
·
१४ मिनेट पहिले
Power Integrations Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Simply Wall Street
·
४ मिनेट पहिले
What Could Space Exploration Technologies (SPCX) Merger Talk Mean For Shareholders?
Stocktwits
·
१ घण्टा पहिले
Nasdaq 100 Records Worst Week In 18 Months As Investors Steer Clear Of Chipmakers — AAPL, MSTR, UBER, SOXX In Focus
CNN
·
४ घण्टा पहिले
Nasdaq sinks more than 2% as investors raise questions about AI debt
Profile
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
About Concord Biotech Ltd